References
The full list of guidelines, trials and public resources this site relies on.
Sources used across the site
- Nehra A, Alterowitz R, Culkin DJ, et al. Peyronie's Disease: AUA Guideline. J Urol. 2015;194(3):745-753. doi:10.1016/j.juro.2015.05.098 Open source (opens in a new tab)
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. doi:10.1016/j.juro.2018.05.004 Open source (opens in a new tab)
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. doi:10.1016/j.juro.2018.03.115 (AUA: reviewed and validity confirmed 2024) Open source (opens in a new tab)
- Schlegel PN, Sigman M, Collura B, et al. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I. J Urol. 2021;205(1):36-43. doi:10.1097/JU.0000000000001521 Open source (opens in a new tab)
- Brannigan RE, Hermanson L, Kaczmarek J, Kim SK, Kirkby E, Tanrikut C. Updates to Male Infertility: AUA/ASRM Guideline (2024). J Urol. 2024;212(6):789-799. doi:10.1097/JU.0000000000004180 Open source (opens in a new tab)
- European Association of Urology. EAU Guidelines on Sexual and Reproductive Health, 2026 edition (limited update of the 2025 text). Arnhem: EAU Guidelines Office; 2026. Open source (opens in a new tab)
- Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199-207. doi:10.1016/j.juro.2013.01.087 Open source (opens in a new tab)
- U.S. Food and Drug Administration. XIAFLEX (collagenase clostridium histolyticum) prescribing information, including the boxed warning on corporal rupture. Open source (opens in a new tab)
- Ziegelmann M, Savage J, Toussi A, et al. Outcomes of a novel penile traction device in men with Peyronie's disease: a randomized, single-blind, controlled trial. J Urol. 2019;202:599. (ClinicalTrials.gov NCT03389854) Open source (opens in a new tab)
- Moncada I, Krishnappa P, Romero J, et al. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. BJU Int. 2019;123:694. Open source (opens in a new tab)
- Yang D, Ziegelmann MJ. Penile traction therapy for Peyronie's disease. AUANews. April 2021. Open source (opens in a new tab)
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. doi:10.1056/NEJMoa2215025 Open source (opens in a new tab)
- Belker AM, Thomas AJ, Fuchs EF, Konnak JW, et al. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol. 1991;145(3):505-511. doi:10.1016/S0022-5347(17)38381-7 Open source (opens in a new tab)
- World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition. Geneva: WHO; 2021. Open source (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases. Penile Curvature (Peyronie's Disease). NIH; last reviewed August 2019. Open source (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases. Definition & Facts for Erectile Dysfunction. NIH; last reviewed October 2024. Open source (opens in a new tab)
Each link opens the publisher, the journal or a record of the article. Guidelines are revised from time to time, and the publisher page always carries the latest version.